-
Biologics: Targets & Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Biologics: Targets & Therapy
(402,758) Views
Editor in Chief Professor Doris Mangiaracina Benbrook
1177-5475
Current and future applications of the anti-IgE antibody omalizumabCristoforo Incorvaia, Marina Mauro, Gian Galeazzo Riario-Sforza, Franco Frati, Francesco Tarantini, Maurizio Caserini
Review of tocilizumab in the treatment of rheumatoid arthritis
Yasuaki Okuda
Erlotinib in the treatment of advanced pancreatic cancer
Robin K Kelley, Andrew H Ko
Sunitinib for advanced renal cell cancer
Chris Coppin
Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
Archana Monie, Chien-Fu Hung, Richard Roden, T-C Wu
Infliximab for the treatment of plaque psoriasis
Jennifer S Gall, Robert E Kalb
The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn's disease - An interview with David A Schwartz, 13 June 2007
David A Schwartz
Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
Andrea Pession, Fraia Melchionda, Claudia Castellini
Garlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL
Greg Hodge, Stephen Davis, Michael Rice, Heather Tapp, Ben Saxon, Tamas Revesz
Activity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the inhibition of adhesion molecule expression on human umbilical vascular endothelial cells
Torsten Hans Schroeder, Wolfgang Artur Krueger, Hans-Jürgen Dieterich, Boris Nohé
The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
Terry Golombick, Terry Diamond
A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers
Robert C Fang, Robert D Galiano
Clinical uses of GM-CSF, a critical appraisal and update
Martha Arellano, Sagar Lonial
Abciximab: a reappraisal of its use in coronary care
Marco Valgimigli, Gianluca Campo, Matteo Tebaldi, Roberto Carletti, Chiara Arcozzi, et al
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
Marco Montillo, Francesca Ricci, Sara Miqueleiz, Alessandra Tedeschi, Enrica Morra
Bevacizumab in the therapy for refractory metastatic colorectal cancer
Mary F Mulcahy
Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
Bella Kaufman, Steven Stein, Michelle A Casey, Beth O Newstat
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed




